RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease
European Respiratory Journal · 2024-11 · 64 (5) · 2300844
DOI: 10.1183/13993003.00844-2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 14.11.2024. Verfasst von Shao-Fei Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Physiology, Charité - Universitätsmedizin Berlin, corporate member of the Free University Berlin and the Humboldt University Berlin, Be…. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 1 Subunit, Pulmonary Artery, Vascular Remodeling, Vascular Calcification. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: China Scholarship Council, Bundesministerium für Bildung und Forschung, Austrian Science Fund.
Abstract (Originalsprache)
Background
Calcification is common in chronic vascular disease, yet its role in pulmonary hypertension due to left heart disease is unknown. Here, we probed for the role of runt-related transcription factor-2 (RUNX2), a master transcription factor in osteogenesis, and its regulation by the HIPPO pathway transcriptional coactivator with PDZ-binding motif (TAZ) in the osteogenic reprogramming of pulmonary artery smooth muscle cells and vascular calcification in patients with pulmonary hypertension due to left heart disease. We similarly examined its role using an established rat model of pulmonary hypertension due to left heart disease induced by supracoronary aortic banding.
Methods
Pulmonary artery samples were collected from patients and rats with pulmonary hypertension due to left heart disease. Genome-wide RNA sequencing was performed, and pulmonary artery calcification assessed. Osteogenic signalling via TAZ and RUNX2 was delineated by protein biochemistry. In vivo , the therapeutic potential of RUNX2 or TAZ inhibition by CADD522 or verteporfin was tested in the rat model.
Results
Gene ontology term analysis identified significant enrichment in ossification and osteoblast differentiation genes, including RUNX2 , in pulmonary arteries of patients and lungs of rats with pulmonary hypertension due to left heart disease. Pulmonary artery calcification was evident in both patients and rats. Both TAZ and RUNX2 were upregulated and activated in pulmonary artery smooth muscle cells of patients and rats. Co-immunoprecipitation revealed a direct interaction of RUNX2 with TAZ in pulmonary artery smooth muscle cells. TAZ inhibition or knockdown decreased RUNX2 abundance due to accelerated RUNX2 protein degradation rather than reduced de novo synthesis. Inhibition of either TAZ or RUNX2 attenuated pulmonary artery calcification, distal lung vascular remodelling and pulmonary hypertension development in the rat model.
Conclusion
Pulmonary hypertension due to left heart disease is associated with pulmonary artery calcification that is driven by TAZ-dependent stabilisation of RUNX2, causing osteogenic reprogramming of pulmonary artery smooth muscle cells. The TAZ–RUNX2 axis may present a therapeutic target in pulmonary hypertension due to left heart disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Physiology, Charité - Universitätsmedizin Berlin, corporate member of the Free University Berlin and the Humboldt University Berlin, Berlin, Germany.
- DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
- These authors contributed equally to the study.
- Institute for Physiology, Charité - Universitätsmedizin Berlin, corporate member of the Free University Berlin and the Humboldt University Berlin, Berlin, Germany mariya.kucherenko@dhzc-charite.de.
- Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.
- Charité - Universitätsmedizin Berlin, corporate member of the Free University Berlin and the Humboldt University Berlin, Berlin, Germany.
ORCID-Profile: Shao-Fei Liu, Mariya M Kucherenko, Christoph Knosalla, Wolfgang M Kuebler
Förderung
- China Scholarship Council
- Bundesministerium für Bildung und Forschung
- Austrian Science Fund
- Deutsche Forschungsgemeinschaft
- Deutsches Zentrum für Herz-Kreislaufforschung
Zitieren
APA
Liu, S. F., Kucherenko, M. M., Sang, P., Li, Q., Yao, J., Nambiar Veetil, N., Gransar, T., Alesutan, I., Voelkl, J., Salinas, G., Grune, J., Simmons, S., Knosalla, C., & Kuebler, W. M. (2024). RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease. European Respiratory Journal, 64(5), 2300844. https://doi.org/10.1183/13993003.00844-2023
Vancouver
Liu SF, Kucherenko MM, Sang P, Li Q, Yao J, Nambiar Veetil N, et al. RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease. European Respiratory Journal. 2024;64(5):2300844. doi:10.1183/13993003.00844-2023
BibTeX
@article{Liu2024,
author = {Liu, Shao-Fei and Kucherenko, Mariya M and Sang, Pengchao and Li, Qiuhua and Yao, Juquan and Nambiar Veetil, Netra and Gransar, Tara and Alesutan, Ioana and Voelkl, Jakob and Salinas, Gabriela and Grune, Jana and Simmons, Szandor and Knosalla, Christoph and Kuebler, Wolfgang M},
title = {RUNX2 is stabilised by TAZ and drives pulmonary artery calcification and lung vascular remodelling in pulmonary hypertension due to left heart disease},
journal = {European Respiratory Journal},
year = {2024},
volume = {64},
number = {5},
pages = {2300844},
doi = {10.1183/13993003.00844-2023}
}
EUVIMED